Johnson & Johnson Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (124)

Latest Posts

About This Stock More About This Stock
Premarket Biotech Digest – BDX Finalizes Acquisition Deal, VNLPF Receives CRL, EYEG Files S-1
Article By: KKD Healthcare Analytics
Monday, April 24, 2017 10:03 AM EDT
Johnson & Johnson announced results from a Phase 2 clinical trial assessing the triple combination ofOlysio (simeprevir), C.R. Bard Inc. and Becton Dickinson finalize the deal for buying Bard.
In this article: BCR, JNJ, MRK, NVO, VNLPF, XOMA, EYEG, ARGNF, BDX
Read
Samsung Bioepis' Knockoff Latest Competition For Johnson & Johnson's Blockbuster, Remicade
Article By: Lorimer Wilson
Friday, April 21, 2017 8:34 PM EDT
JNJ’s Remicade earned close to $7 billion last year, making it by far the biggest drug in their portfolio but the FDA has approved a new knockoff which may finally start to shift the market dynamics toward greater competition with lower prices.
In this article: JNJ, MRK, NVS, PFE, BIIB
Read
Johnson & Johnson: Modest Price Decline Presents Buying Opportunity
Article By: SureDividend
Friday, April 21, 2017 10:51 AM EDT
The stock of a stable company like Johnson & Johnson does not typically undergo rapid price fluctuations. However, the company’s stock price decline by ~3% on Tuesday after the company reported earnings for the first quarter of 2017.
In this article: JNJ Also: MSFT
Read
Recent Stock Purchase II April 2017
Article By: Keith Park
Thursday, April 20, 2017 4:39 AM EDT
Mr. Market always has the last word and that sometimes stocks that I’m not considering in a particular month may suddenly become attractive once again because of a serious sell-off (usually after poor earning reports and guidance).
In this article: CAH, GIS, GWW, JNJ
Read
Up And Down
Article By: Marvin R Clark
Tuesday, April 18, 2017 11:38 PM EDT
One day up, one day down. Confidence in the U.S. economy is at its lowest point in five months. Gallup’s US Economic Confidence Index was +4 for the week ending April 16, down two points from a week earlier.
In this article: BAC, C, GLW, GS, IBM, JNJ, JPM, T, VZ, MSFT, SNAP
Read

PARTNER HEADLINES

Latest Tweets for $JNJ

No tweets yet!